基金经理：吴兴武
| 单位净值:1.0781 | 净值增长率:-0.51% | 净值增长率:-0.51% | 累计净值:1.0781 | 截止日期:2026/10/9 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:1.85亿元 | 风险等级:中高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
广发沪港深医药混合A(014114)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2026/6/30 | 533,020,000 | - | 738,589,000 | 726,264,000 | 73% |
| 2026/3/31 | 725,746,000 | - | 955,015,000 | 830,218,000 | 87% |
| 2025/12/31 | 509,487,000 | - | 735,837,000 | 590,146,000 | 86% |
| 2025/9/30 | 695,294,000 | - | 753,359,000 | 741,813,000 | 94% |
| 2025/6/30 | 286,009,000 | - | 308,465,000 | 306,824,000 | 93% |
| 2025/3/31 | 279,547,000 | - | 317,935,000 | 306,648,000 | 91% |
| 2024/12/31 | 232,740,000 | - | 280,921,000 | 279,590,000 | 83% |
| 2024/9/30 | 279,618,000 | - | 329,128,000 | 327,669,000 | 85% |
| 2024/6/30 | 263,215,000 | - | 296,159,000 | 295,001,000 | 89% |
| 2024/3/31 | 276,522,000 | 120,688 | 312,616,000 | 311,565,000 | 89% |
| 2023/12/31 | 305,907,000 | - | 341,805,000 | 340,324,000 | 90% |
| 2023/9/30 | 329,757,000 | - | 414,477,000 | 402,268,000 | 82% |
| 2023/6/30 | 309,082,000 | - | 341,138,000 | 339,737,000 | 91% |
| 2023/3/31 | 341,804,000 | - | 379,146,000 | 360,172,000 | 95% |
| 2022/12/31 | 348,032,000 | - | 378,820,000 | 374,481,000 | 93% |
| 2022/9/30 | 305,860,000 | - | 328,613,000 | 327,041,000 | 94% |
| 2022/6/30 | 504,751,000 | - | 550,578,000 | 542,558,000 | 93% |
| 2022/3/31 | 508,449,000 | - | 615,717,000 | 588,688,000 | 86% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。